Hofseth BioCare ASA (HBC.OL)
NOK 1.41
(-23.37%)
NOK 1.41
(-23.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 194.87 Million | 120.44 Million | 87.61 Million | 69.25 Million | 67.77 Million | 60.74 Million |
| Cost of Revenue | 164.99 Million | 91.93 Million | 64.51 Million | 39.53 Million | 59.57 Million | 48.36 Million |
| Gross Profit | 29.87 Million | 28.51 Million | 23.09 Million | 29.72 Million | 8.2 Million | 12.37 Million |
| Operating Expenses | 156.04 Million | 157.13 Million | 141.66 Million | 121.82 Million | 88.55 Million | 90.85 Million |
| Selling, General and Administrative Expenses | 65.48 Million | 32.91 Million | 44.84 Million | 26.53 Million | 12.31 Million | 7.76 Million |
| Research and Development Expenses | 11.01 Million | 13.63 Million | 12.53 Million | 7.56 Million | 131 Thousand | 2.43 Million |
| Other Expenses | 59.08 Million | 1.55 Million | - | -86 Thousand | -8.93 Million | - |
| Cost and Expenses | 297.4 Million | 249.06 Million | 206.18 Million | 161.35 Million | 148.13 Million | 139.21 Million |
| Operating Income | -102.52 Million | -128.61 Million | -118.56 Million | -92.02 Million | -79.57 Million | -77.69 Million |
| Interest Expense | 7.54 Million | 9.95 Million | 9.39 Million | 9.21 Million | 8.57 Million | 3.83 Million |
| Income Tax Expense | - | 1.18 Million | 1.49 Million | -1 Million | -1.27 Million | 249 Thousand |
| Earnings before Tax | -106.68 Million | -137.39 Million | -126.46 Million | -102.09 Million | -89.21 Million | -84.52 Million |
| Net Income | -106.68 Million | -137.38 Million | -126.46 Million | -102.09 Million | -89.2 Million | -84.76 Million |
| Earnings Per Share Basic | -0.27 | -0.37 | -0.35 | -0.31 | -0.29 | -0.33 |
| Earnings Per Share Diluted | -0.27 | -0.37 | -0.35 | -0.31 | -0.29 | -0.33 |
| Weighted Average Shares Outstanding | 395.08 Million | 374.73 Million | 357.83 Million | 333.65 Million | 307.29 Million | 258.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 395.08 Million | 374.73 Million | 357.83 Million | 333.65 Million | 307.29 Million | 258.99 Million |
| Gross Margin | 0.15 | 0.24 | 0.26 | 0.43 | 0.12 | 0.20 |
| EBIT Margin | -0.36 | -0.81 | -1.00 | -0.96 | -0.79 | -0.94 |
| Profit Margin | -0.55 | -1.14 | -1.44 | -1.47 | -1.32 | -1.40 |
| EBITDA | -70.6 Million | -97 Million | -85.56 Million | -68.28 Million | -55.49 Million | -58.5 Million |
| Earnings Before Tax Margin | -0.53 | -1.07 | -1.35 | -1.33 | -1.17 | -1.28 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 72.18 Million | 52.09 Million | 190.81 Million | 45.88 Million | 49.73 Million | 52.94 Million |
| Cost of Revenue | 68.94 Million | 53.42 Million | 245.37 Million | 76.41 Million | 33.86 Million | 27.08 Million |
| Gross Profit | 3.23 Million | -1.32 Million | -54.55 Million | -30.52 Million | 15.87 Million | 25.85 Million |
| Operating Expenses | 23.01 Million | 24.88 Million | 71.6 Million | 18.75 Million | 42.18 Million | 40.96 Million |
| Selling, General and Administrative Expenses | 22.64 Million | 23.89 Million | - | 20.29 Million | 17.67 Million | 20.13 Million |
| Research and Development Expenses | 1.24 Million | 1.24 Million | - | - | - | - |
| Other Expenses | 873 Thousand | 261 Thousand | -6.12 Million | 1.53 Million | 114 Thousand | 2.16 Million |
| Cost and Expenses | 91.96 Million | 78.3 Million | 316.98 Million | 95.16 Million | 76.05 Million | 68.05 Million |
| Operating Income | -19.78 Million | -26.2 Million | -126.16 Million | -49.28 Million | -20.62 Million | 8.37 Million |
| Interest Expense | 3.63 Million | 3.27 Million | 7.54 Million | 427 Thousand | 2.23 Million | 2.58 Million |
| Income Tax Expense | 1.83 Million | 810 Thousand | -2.54 Million | 2.48 Million | 9.04 Million | -35 Thousand |
| Earnings before Tax | -15.73 Million | -28.19 Million | -109.22 Million | -49.4 Million | -22.71 Million | 5.76 Million |
| Net Income | -17.56 Million | -29 Million | -106.68 Million | -51.89 Million | -22.71 Million | 5.76 Million |
| Earnings Per Share Basic | -0.04 | -0.07 | - | -0.13 | -0.06 | 0.01 |
| Earnings Per Share Diluted | -0.04 | -0.07 | - | -0.13 | -0.06 | 0.01 |
| Weighted Average Shares Outstanding | 411.08 Million | 410.37 Million | 395.08 Million | 395.08 Million | 395.08 Million | 395.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 411.08 Million | 410.37 Million | 395.08 Million | 395.08 Million | 395.08 Million | 396.25 Million |
| Gross Margin | 0.04 | -0.03 | -0.29 | -0.67 | 0.32 | 0.49 |
| EBIT Margin | -0.16 | -0.34 | - | -0.87 | -0.23 | 0.35 |
| Profit Margin | -0.24 | -0.56 | -0.56 | -1.13 | -0.46 | 0.11 |
| EBITDA | -11.43 Million | -17.47 Million | - | -39.78 Million | -11.62 Million | 18.29 Million |
| Earnings Before Tax Margin | -0.27 | -0.50 | -0.66 | -1.07 | -0.41 | 0.16 |
BPOST
ECDP
ELOX
1215
3005
WTN